EntheogeniX Biosciences

EntheogeniX Biosciences, founded in 2019, is a biotech company focused on advancing psychedelic research to develop innovative mental health therapeutics. With the slogan "Novel Mental Health Therapeutics, Inspired by Psychedelics," the company is dedicated to addressing mental health conditions such as depression, bipolar disorder, and schizophrenia. Using cutting-edge technologies like artificial intelligence and computational biophysics, Entheogenix is leveraging a data-driven pipeline to uncover new medicines from desired psychedelics to benefit patients. The company operates within the AI, Biotechnology, and Pharmaceutical industries. As for investments, the last investment round and associated investors are not explicitly stated.